Principal Investigator at CAPER (current)
“Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment”
Principal Investigator: Laura MacPherson, Ph.D.
Agency: American Cancer Society
Type and Number: RSGT1101101CPPB
Period: 01/01/11-12/31/14
Total Costs = $898,000
“Soft Commitment as a Mechanism to Prevent Preference Reversal”
Principal Investigator: Richard Yi, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R01DA011692
Period: 09/09/10-02/28/14
Total Costs = $1,149,200
“Integration of Basic Neuroscience Research into Addiction Treatment Development”
Principal Investigator: Carl W. Lejuez, Ph.D. (Co-PI: Cynthia Moss, Ph.D.)
Agency: National Institute of Drug Abuse
Type and Number: T32 DA28855 (Institutional Pre-doctoral Training Program)
Period: 7/15/10-6/30/15
Total Costs = $759,000
“Behavioral Technologies for Predicting HIV Risk”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA18647 (Competitive Renewal years 6-10, previous PI: Lejuez)
Period: 7/1/10-4/30/15
Total Costs = $2,957,000
“Stage II Trial of Novel Behavioral Activation Intervention for Smoking Cessation”
Principal Investigator: Laura MacPherson, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R01 DA018730 (Competitive Renewal years 4-7, previous PI: Lejuez)
Period: 7/1/10-5/31/14
Total Direct Costs: $1,475,000
“Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation”
Principal Investigator: Laura MacPherson, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R01 DA018730
Period: 5/10/10-4/30/13
Total Direct Costs: $600,000
“Novel Intervention for Drug Use and HIV Risk among Anxiety Sensitive Heroin Users“
Principal Investigator: Carl W. Lejuez, Ph.D
Agency: National Institute on Drug Abuse
Type and Number: R01 DA23384
Period: 08/01/09 – 07/31/11
Total Costs = $750,000
“Behavioral Measurement of Negative Reinforcement in Adolescent Alcohol Use/Abuse”
Principal Investigator: Carl W. Lejuez, Ph.D
Agency: National Institute of Alcohol Abuse, and Alcoholism
Type and Number: R21 AA17685
`qPeriod: 04/10/09 – 03/31/11
Total Costs = $400,000
“Drug Choice, Impulsivity, and Risky Sexual Behavior”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse R01
Type and Number: R01 DA19405
Period: 6/01/06 – 5/31/11
Total Costs = $1,250,000
Principal Investigator at CAPER (past)
“Behavioral Treatment for Depressed Smokers”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse R01
Type and Number: R01 DA18730
Period: 10/01/05 – 6/30/09
Total Costs = $1,100,000
“Behavioral Technologies for Predicting HIV Risk”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA18647
Period: 7/1/05-6/30/10
Total Costs = $1,640,000
“Behavioral Technologies for Predicting HIV Risk: Genetics Administrative Supplement”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA18647-S2
Period: 9/1/06-6/30/10
Total Costs = $196,000
“Behavioral Technologies for Predicting HIV Risk: Environmental Assessment Administrative Supplement”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA18647-S3
Period: 9/1/08-6/30/10
Total Costs = $140,000
“Distress Tolerance and Early Smoking Lapse”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA15375
Period: 8/15/03 – 5/31/07
Total Costs = $869,000
“Distress Tolerance and Early Smoking Lapse: Cortisol Administrative Supplement”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA15375-S2
Period: 8/15/05 – 5/31/07
Total Costs = $74,500
“A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nalmefene HCl in the Treatment of Pathological Gambling”
Principal Investigator: Carl W. Lejuez, Ph.D.
Source: Somaxon Pharmaceuticals
Period: 7/1/05-6/30/06
Total Costs = $12,675
“Testing a Behavioral Predictor of HIV Risk”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R21 DA14699
Period: 10/1/02 – 9/30/05
Total Costs = $289,000
“Collaborative Mentoring in the Integration of Basic Cognitive Science and the Assessment and Treatment of Addictive Behaviors”
Co-Principal Investigators: Carl W. Lejuez, Ph.D. & Thomas S. Wallsten, Ph.D.
Agency and Type: University of Maryland Scholarship in Teaching and Learning
Period: 6/1/02 – 5/31/03
Total Costs = $3,500
Co-Investigator from CAPER on Grants Housed Elsewhere (current)
“Depression Treatment for Urban Low Income Minority Substance Users"
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number:
R01 DA26424
Period: 4/1/10-3/30/15
Total Direct Costs: $1,475,000
“Behavioral
Depression Treatment for African American HIV-infected Substance Users” Principal
Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA22974
Period: 9/1/08-6/30/12
Total Costs: $1,400,000
*“Distress
Tolerance: Links with Family Emotional Climate and Adolescent HIV Risk”
Principal Investigator: Jude Cassidy, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA25550
Period: 9/1/08-6/30/10
Total Costs: $400,000
“PTSD and Predictors of Residential Drug Treatment
Drop Out”
Principal Investigator: Matthew T. Tull, Ph.D.
PI Affiliation: University of Mississippi Medical Center
Co-Investigator:
Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R21 DA22383
Period: 5/1/07 - 4/30/07
Total Costs = $400,000
*“Predictors of Drug-Related Attentional Bias among Crack/Cocaine Users with PTSD”
Principal Investigator: Matthew T. Tull, Ph.D.
Co-Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R03 DA023001
Period: 5/1/2007 - 4/30/2007
Total Costs: $74,000
*“Distress Tolerance and Adolescent Substance Use”
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R21 DA022741-01A1
Period: 9/1/07 - 8/30/09
Total Costs: $400,000
“Integrated Treatment for Depressed Mothers of ADHD Children”
Principal Investigator: Andrea M. Chronis, Ph.D.
Agency: National Institute of Mental Health
Type and Number: R34 MH073567-01A1
Period: 3/15/06-12/31/08
Total Costs: $646,102
Co-Investigator (Subcontract) with PI elsewhere
“Toward an Institute of Child Development in Bucharest Romania”
Principal Investigator: Charles Nelson, Ph.D.
PI Affiliation: Children’s Hospital Boston
Co-Investigator: Catalina Kopetz, Ph.d.
Prime Agency: MacArthur Foundation
Type and Number: N/A
Period: 06/01/10-08/31/11
Total Subcontract Costs: $12,478
“Evaluation of Novel PTSD Risk Assessment Tools for Disaster-Exposed Youth”
Principal Investigator: Carla K. Danielson, Ph.D.
PI Affiliation: Medical University of South Carolina
Co-Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R21 MH86313
Period: 7/01/09 – 6/31/11
Total Subcontract Costs = $29,000
"Treatment of Cocaine Addiction with Integrative Meditation"
Principal Investigator: Kevin Chen, Ph.D.
PI Affiliation: University of Maryland School of Medicine
Agency: National Institute of Drug Abuse
Type and Number: R21 DA25149
Period: 4/01/09 – 3/31/11
Total Subcontract Costs = $32,000
“Panic Disorder, Smoking, and Related Medical Problems”
Principal Investigator: Michael J. Zvolensky, Ph.D.
PI Affiliation: University of Vermont
Agency: National Institute of Drug Abuse
Type and Number: R21 DA16227
Period: 8/01/03 – 5/31/06
Total Subcontract
Costs = $42,000
Primary Mentor on Junior Faculty and Student Grants
“HPA Axis Reactivity To Stress In Chronic Cocaine Users And Healthy Control”
Principal Investigator: Jessica Richards, B.A.
Agency: National Institute of Drug Abuse
Type and Number: F31 National Research Service Award Fellowship DA27242
Period: 6/1/10 – 5/31/13
Total Costs: $100,386
“Examining The Effect Of Behavioral Activation On Substance Use Outcomes”
Principal Investigator: Jessica Magidson, B.A.
Agency: National Institute of Drug Abuse
Type and Number: F31 National Research Service Award Fellowship DA26679
Period: 4/15/10 – 4/14/13
Total Costs: $41,341
“Behavioral Technologies for Preventing HIV Risk: Minority Supplement”
Principal Investigator: Andres De Los Reyes
Agency: National Institute on Drug Abuse
Type and Number: R01DA018647-S1
Period: 07/01/09-06/30/11
Total Costs: $78,506
“Implicit & Explicit Mechanisms in Crack Cocaine & Sex Trade Association”
Principal Investigator: Catalina Kopetz, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: F32 DA 026253
Period: 06/19/09-06/18/11
Total Costs: $97,264
“Distress Tolerance
and Adolescent Smoking Cessation”
Principal Investigator: Laura MacPherson, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: K23 DA023143
Project Period: 04/01/08 – 3/31/11
Total Costs:
$750,000
“Drug Choice, Impulsivity, and Risky Sexual Behavior: Minority Supplement”
Principal Investigator: Tanya Geiger, M.A. (Public Health PhD student)
Agency: National Institute of Drug Abuse
Type: Minority Supplement to R01 DA18730
Period: 06/01/08 – 5/31/10
Total Costs: $80,854
“Risk Factors in the Relationship between Gender and Crack Cocaine”
Principal Investigator: Elizabeth K. Reynolds, B.A.
Agency: National Institute of Drug Abuse
Type and Number: F31 National Research Service Award Fellowship DA23302
Period: 09/17/10-02/01/10
Total Costs: $97,938
“Distress Tolerance Treatment for Inner-City Drug Users”
Principal Investigator: Marina A. Bornovalova, M.A.
Agency: National Institute of Drug Abuse
Type and Number: R36 Dissertation Research DA21820
Period: 10/01/06 – 9/30/08
Total Costs = $140,000
“Anxiety Vulnerabilities in Heroin Users”
Principal Investigator: Autumn Paulson, M.A.
Agency: National Institute of Drug Abuse
Type and Number: F31 National Research Service Award Fellowship DA20406
Period: 10/01/06 – 9/30/08
Total Costs = $77,336
“Behavioral Treatment for Depressed Smokers: Minority Supplement”
Principal Investigator: Tyish Hall Brown, M.A.
Agency: National Institute of Drug Abuse
Type: Minority Supplement to R01 DA18730
Period: 06/01/06 – 5/31/08
Total Costs = $72,820
“Behavioral Technologies for Predicting HIV Risk: Minority Supplement”
Principal Investigator: Marsha Sargeant, B.A.
Agency: National Institute of Drug Abuse
Type: Minority Supplement to R01 DA18647
Period: 06/01/06 – 5/31/10
Total Costs = $178,292
“Distress Tolerance and Drug Treatment Drop-out”
Principal Investigator: Stacey B. Daughters, M.A.
Agency: National Institute of Drug Abuse
Type and Number: R36 Dissertation Research DA018387
Period: 9/01/04 – 6/30/07
Total Costs = $140,000
“Impulsivity Processes Underlying Drug Choice and Sexual Risk”
Principal Investigator: Marina Bornovalova, B.A.
Agency: National Institute of Drug Abuse
Type and Number: F31 National Research Service Award Fellowship DA18506
Period: 8/15/04 – 9/31/06
Total Costs = $69,571
“Distress Tolerance and Early Smoking Lapse: Minority Supplement”
Principal Investigator: Adria-J. Trotman, M.A.
Agency: National Institute of Drug Abuse
Type: Minority Supplement to R01 DA15375
Period: 02/01/04 – 8/14/06
Total Costs = $65,715
“Risk-taking Behaviors and African American Adolescents”
Principal Investigator: Will M. Aklin, M.A.
Agency: National Institute of Drug Abuse
Type: F31 Minority National Research Service Award Fellowship
Period: 10/01/03 – 9/31/06
Total Costs = $75,000